LAWRENCEVILLE, N.J., Dec. 19, 2016 -- 1WorldSync, the leading multi-enterprise product information network, has partnered with Globizz, a market-leading FDA solution provider. The partnership gives enhanced access to UDI database registration and FDA compliance solutions for Japanese healthcare companies seeking to export products to the U.S. market.
|
|||
1WorldSync is the only certified GDSN data pool operating in Japan equipped to help customers meet UDI requirements in the local language. The partnership allows Globizz customers to leverage 1WorldSync’s deep experience in UDI compliance within the medical device market and provides additional consulting services for Japanese healthcare companies expanding to the U.S.
“With the highly regulated nature of the medical device market, businesses require advanced support to meet the product information requirements necessary to sell their products across borders,” said Dan Wilkinson, Chief Commercial Officer of 1WorldSync. “Our dedicated staff of UDI database registration experts in Japan, in tandem with Globizz’s FDA compliance solutions, will provide Japanese companies the support and expertise to scale and distribute product information that complies with today’s regulations.”
Compliance with FDA regulations for the medical device industry requires barcodes to be placed on the device label/packaging and device data elements to be submitted to the FDA’s Global UDI Database (GUDID). Globizz partnered with 1WorldSync, a world leader in the product data industry, for its recognition as a qualified UDI issuing agency by the FDA. This partnership enables easier data management and global expansion while eliminating the language barriers Japanese healthcare companies encounter while seeking to export products into the U.S. market.
“This partnership will allow Globizz to continue to offer the highest quality consulting services in a timely manner, support client’s barcode needs and help expand businesses in both the U.S. and Japan,” said Takahiro Harry Haruyama, President and CEO of Globizz. “As partners, Globizz and 1WorldSync will assist in the full compliance of UDI requirements for the Japanese medical device industry, which is an important element to their success in the U.S.”
For more information, visit www.1worldsync.com.
About 1WorldSync
1WorldSync is the leading multi-enterprise product information network, helping more than 25,000 global brands and their trading partners in over 60 countries – share authentic, trusted content in the hands of their customers and consumers, empowering consumers to make the right choices, purchases, health and lifestyle decisions. Through its solutions, technology platform and expert services, 1WorldSync provides solutions that meet the diverse needs of its customers. For more information, please visit http://www.1worldsync.com
About Globizz
Based in California, Globizz is an international consulting company with extensive experience in cross-border business. Globizz provides FDA consulting services for medical devices, medical drugs, foods, supplements, cosmetics, animal feeds and other biotech products.
Globizz specializes in advising on overseas expansion plans for top-level management businesses and financial planning, as well as market research, overseas base auditing, and cross border M&A advisory between the U.S. and Japan. It also provides on-site personnel training and seminars, and directors for overseas entities. For more information, please visit www.globizz.net.
Media Contact Rachel Gulden [email protected] 312-267-0530


7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 



